Trevi Therapeutics, Inc. (TRVI) › EPS (Basic)Trevi Therapeutics, Inc. (TRVI) — EPS (Basic)Annual figures by period end, from SEC filings.2021-12-31: $-1.492022-12-31: $-0.452023-12-31: $-0.292024-12-31: $-0.472025-12-31: $-0.32$-0.322021-12-31EPS (Basic) (USD/shares)2025-12-31Period endedEPS (Basic)Change YoYSource filing2025-12-31$-0.32—2026-03-17From 2025-01-012024-12-31$-0.47—2026-03-17From 2024-01-012023-12-31$-0.29—2025-03-18From 2023-01-012022-12-31$-0.45—2024-03-20From 2022-01-012021-12-31$-1.49—2023-03-16From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares